Daejeon, South Korea

Hyeongkyu Lee

This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 1 EPO patent. Top assignees: Korea Research Institute of Bioscience and Biotechnology, Yungjin Pharmaceutical Co., Ltd.. Active years: 2017-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyeongkyu Lee. Retrieved from https://idiyas.com/inventor/hyeongkyu-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0


 

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2017-2018

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Hyeongkyu Lee: A Pioneer in Health-Related Inventions

Introduction

Hyeongkyu Lee, an inventive mind from Daejeon, South Korea, has made significant contributions to the field of health and biotechnology. With a remarkable portfolio of four patents, he has focused on developing innovative methods to improve therapeutic solutions for various diseases. His work showcases the intersection of biotechnology and health, providing promising avenues for future treatments.

Latest Patents

Among Hyeongkyu Lee's latest inventions is an industrialized method for preparing a purified extract that contains abundant active ingredients, specifically catalpol derivatives. This novel approach aims to enhance the efficacy of therapeutic agents for treating and preventing inflammatory, allergic, or asthmatic diseases. Through rigorous in vivo tests, the purified extract demonstrated potent anti-inflammatory, anti-allergy, and anti-asthma activities when compared to conventional preparation methods. These tests included inhibition tests on eosinophil reproduction, immunoglobulin release, and inflammatory chemokines in both plasma and bronchoalveolar fluid, alongside the suppression of airway hyperresponsiveness and goblet cell hyperplasia in a mouse model.

Career Highlights

Hyeongkyu Lee has been associated with reputable organizations during his career, including Yungjin Pharmaceutical Co., Ltd. and the Korea Research Institute of Bioscience and Biotechnology. His tenure in these institutions has played a crucial role in his development as an inventor, allowing him to apply his innovative methods to real-world challenges in biotechnology.

Collaborations

Throughout his career, Hyeongkyu Lee has collaborated with notable colleagues, including Yongnam Lee and Ji-seok Yoo. These professional relationships have fostered an environment of creative ideas and have contributed to the advancement of his research and innovations.

Conclusion

Hyeongkyu Lee's contributions to the field of health and biotechnology stand as a testament to his innovative spirit and dedication. With his impressive track record of patents and collaborations, he continues to pave the way for advancements that could significantly improve therapeutic outcomes for various health conditions. As he progresses in his career, the impact of his work will likely resonate in the realms of medicine and health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…